What is molecular diagnostics (MDx)?

Molecular diagnostics (MDx) identify and quantify the presence of biomarkers or genetic material which are linked to different types of diseases. MDx tests are carried out at laboratories or other decentralised testing locations such as specialised departments within hospitals using molecular techniques such as PCR, real-time PCR (rtPCR), qPCR or sequencing. Large infrastructure investments in molecular diagnostics laboratories since the covid-19 pandemic, along with rapid development of new diagnostic technologies will open up growth opportunities across a broad range of applications from companion diagnostics to infectious disease screening. Clearstate offers market data, forecasts, and trend predictions to give you the insight to adjust your business strategy to meet the growing opportunities in molecular diagnostics.

MDx market analysis and updates

Our MDx hub is regularly updated to share our findings on this fast-growing diagnostic market segment. Explore the latest in MDx technology and test applications as new solutions are developed and adopted in the market. Understand the implications of the emergence of MDx alternatives to traditional culture-based testing and immunoassays, and examine the issues that arise from growing competition in this segment of the market. Discover more IVD insights or learn how our IVD Gateway solution can help prepare your business for the future impact of the world’s expanding molecular diagnostic testing capacities. 

Explore how Clearstate can enable your business to stay ahead in the market, inquire now.

Explore the latest MDx market insights

From market news to analysis, our articles provide concise and up-to-date information about the developments driving MDx market growth. Uncover the challenges and opportunities countries face to enable personalised treatment, disease monitoring and improve patient outcomes for the population through molecular diagnostics.

Understand the molecular diagnostics market

In order to determine the future outlook of the MDx market, we must first understand and integrate macro insights on population trends, epidemiology, reimbursement, local affordability levels, testing landscape.

Clearstate newsletter

Sign up to our newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts.